CD68 and cholestasis: The characterization of NPCs in suspension using flow cytometry demonstrated that the proportion of CD68+ cells in the control liver tissues was on average 10%, in contrast to a more than two times higher proportion of CD68+ cells in the case of one donor with bile duct carcinoma and cholestasis.